Connection

Matteo Bassetti to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Matteo Bassetti has written about Drug Therapy, Combination.
Matteo Bassetti
Connection Strength
0.285
Drug Therapy, Combination
  1. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther. 2018 10; 16(10):749-761.
    View in: PubMed
    Score: 0.069
  2. Antimicrobial resistance and treatment: an unmet clinical safety need. Expert Opin Drug Saf. 2018 07; 17(7):669-680.
    View in: PubMed
    Score: 0.068
  3. How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? Semin Respir Crit Care Med. 2017 06; 38(3):301-310.
    View in: PubMed
    Score: 0.063
  4. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? Int J Antimicrob Agents. 2017 Feb; 49(2):255-258.
    View in: PubMed
    Score: 0.061
  5. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
    View in: PubMed
    Score: 0.016
  6. Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort. Infection. 2008 Aug; 36(4):358-61.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.